Latest News
Web Date: December 7, 2016

CRISPR creators duke it out in U.S. patent court

Attorneys representing UC Berkeley and the Broad Institute argue over whose patent matters more
Department: Science & Technology
Keywords: biotechnology, intellectual property, CRISPR, CRISPR patent, CRISPR/Cas9, gene editing

In the biggest science showdown of the year, attorneys defending rival CRISPR/Cas9 gene editing patents faced off at the U.S. Patent & Trademark Office (USPTO) in Alexandria, Va., yesterday. The public hearing attracted a large turnout that spilled into two overflow rooms, with one attendee describing it as a “spectator sport” for patent lawyers and investors.

CRISPR technology is regularly hailed as the biggest biotech breakthrough since the DNA-amplifying PCR method was invented. The tool . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society